BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 28012977)

  • 1. Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial.
    Dikmans RE; Negenborn VL; Bouman MB; Winters HA; Twisk JW; Ruhé PQ; Mureau MA; Smit JM; Tuinder S; Eltahir Y; Posch NA; van Steveninck-Barends JM; Meesters-Caberg MA; van der Hulst RR; Ritt MJ; Mullender MG
    Lancet Oncol; 2017 Feb; 18(2):251-258. PubMed ID: 28012977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial.
    Negenborn VL; Young-Afat DA; Dikmans REG; Smit JM; Winters HAH; Don Griot JPW; Twisk JWR; Ruhé PQ; Mureau MAM; Lapid O; Moerman E; van Turnhout AAWM; Ritt MJPF; Bouman MB; Mullender MG
    Lancet Oncol; 2018 Sep; 19(9):1205-1214. PubMed ID: 30104147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer Treatment.
    Lohmander F; Lagergren J; Roy PG; Johansson H; Brandberg Y; Eriksen C; Frisell J
    Ann Surg; 2019 May; 269(5):836-841. PubMed ID: 30308615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term cost-effectiveness of one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage expander-implant reconstruction from a multicentre randomized clinical trial.
    Negenborn VL; Smit JM; Dikmans REG; Winters HAH; Twisk JWR; Ruhé PQ; Mureau MAM; Tuinder S; Eltahir Y; Posch NAS; van Steveninck-Barends JM; van der Hulst RRWJ; Ritt MJPF; Bouman MB; Mullender MG
    Br J Surg; 2019 Apr; 106(5):586-595. PubMed ID: 30835827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Immediate Implant-Based Breast Reconstruction After Mastectomy With and Without Acellular Dermal Matrix Among Women With Breast Cancer: A Randomized Clinical Trial.
    Lohmander F; Lagergren J; Johansson H; Roy PG; Brandberg Y; Frisell J
    JAMA Netw Open; 2021 Oct; 4(10):e2127806. PubMed ID: 34596671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acellular dermal matrices as an adjunct to implant breast reconstruction: Analysis of outcomes and complications.
    Tasoulis MK; Teoh V; Khan A; Montgomery C; Mohammed K; Gui G
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):511-515. PubMed ID: 31706716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct comparison of porcine (Strattice™) and bovine (Surgimend™) acellular dermal matrices in implant-based immediate breast reconstruction.
    Ball JF; Sheena Y; Tarek Saleh DM; Forouhi P; Benyon SL; Irwin MS; Malata CM
    J Plast Reconstr Aesthet Surg; 2017 Aug; 70(8):1076-1082. PubMed ID: 28624524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and patient satisfaction with the use of bovine-derived acellular dermal matrix (SurgiMend™) in implant based immediate reconstruction following skin sparing mastectomy: A prospective observational study in a single centre.
    Headon H; Kasem A; Manson A; Choy C; Carmichael AR; Mokbel K
    Surg Oncol; 2016 Jun; 25(2):104-10. PubMed ID: 27312036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and patient satisfaction after implant-based breast reconstruction with or without acellular dermal matrix: randomized clinical trial.
    Lohmander F; Lagergren J; Johansson H; Roy PG; Frisell J; Brandberg Y
    BJS Open; 2020 Oct; 4(5):811-820. PubMed ID: 32762012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of the use of acellular-dermal matrix to assist implant-based breast reconstruction in a single centre.
    Barber MD; Williams L; Anderson ED; Neades GT; Raine C; Young O; Kulkarni D; Young I; Dixon JM
    Eur J Surg Oncol; 2015 Jan; 41(1):100-5. PubMed ID: 25238954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the use of acellular dermal matrices (ADM) in women undergoing pre-pectoral implant-based breast reconstruction increase operative success versus non-use of ADM in the same setting? A systematic review protocol.
    Cook H; Zargaran D; Glynou SP; Hamilton S; Mosahebi A
    Syst Rev; 2024 Jun; 13(1):153. PubMed ID: 38849880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Multi Centre Canadian Acellular Dermal Matrix Trial (MCCAT): study protocol for a randomized controlled trial in implant-based breast reconstruction.
    Zhong T; Temple-Oberle C; Hofer SO; Beber B; Semple J; Brown M; Macadam S; Lennox P; Panzarella T; McCarthy C; Baxter N;
    Trials; 2013 Oct; 14():356. PubMed ID: 24165392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mastectomy and immediate breast reconstruction using a prosthesis and lower dermal flap: description of five cases].
    Clerico C; Ihrai T; Raoust I; Chignon-Sicard B; Georgiou C; Flipo B
    Ann Chir Plast Esthet; 2012 Dec; 57(6):606-11. PubMed ID: 22868066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial.
    Gschwantler-Kaulich D; Schrenk P; Bjelic-Radisic V; Unterrieder K; Leser C; Fink-Retter A; Salama M; Singer C
    Eur J Surg Oncol; 2016 May; 42(5):665-71. PubMed ID: 26947961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-to-implant breast reconstruction: Higher complication rate vs cosmetic benefits.
    Gschwantler-Kaulich D; Leser C; Salama M; Singer CF
    Breast J; 2018 Nov; 24(6):957-964. PubMed ID: 30230119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of complications after direct-to-implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial.
    Negenborn VL; Dikmans REG; Bouman MB; Winters HAH; Twisk JWR; Ruhé PQ; Mureau MAM; Smit JM; Tuinder S; Hommes J; Eltahir Y; Posch NAS; van Steveninck-Barends JM; Meesters-Caberg MA; van der Hulst RRWJ; Ritt MJPF; Mullender MG
    Br J Surg; 2018 Sep; 105(10):1305-1312. PubMed ID: 29663320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BROWSE: A multicentre comparison of nine year outcomes in acellular dermal matrix based and complete submuscular implant-based immediate breast reconstruction-aesthetics, capsular contracture and patient reported outcomes.
    Wilson RL; Kirwan CC; O'Donoghue JM; Linforth RA; Johnson RK; Harvey JR
    Eur J Surg Oncol; 2022 Jan; 48(1):73-81. PubMed ID: 34836730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Reconstructive Outcomes in Breast Cancer Patients With Preexisting Subpectoral Implants: Implant-Sparing Mastectomy With Delayed Implant Exchange Versus Immediate Tissue Expander Reconstruction.
    Parabkaharan S; Melody M; Trotta R; Lleshi A; Sun W; Smith PD; Khakpour N; Dayicioglu D
    Ann Plast Surg; 2016 Jun; 76 Suppl 4():S332-5. PubMed ID: 27187252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomized Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM.
    Ng TP; Loo BYK; Yong N; Chia CLK; Lohsiriwat V
    Ann Surg Oncol; 2024 May; 31(5):3366-3376. PubMed ID: 38285304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-stage breast reconstruction using Strattice™: A retrospective study.
    Dikmans RE; El Morabit F; Ottenhof MJ; Tuinder SM; Twisk JW; Moues C; Bouman MB; Mullender MG
    J Plast Reconstr Aesthet Surg; 2016 Feb; 69(2):227-33. PubMed ID: 26723835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.